News

In cooperation with Reuters News and Reuters Health, we are proud to provide you with our continuously updated news feed. We select news that applies to physicians in all the major clinical specialties, as well as on finance, science, technology, and other areas.

Global coronavirus cases rise to more than 11 million

By Alistair Bell WASHINGTON (Reuters) - Global coronavirus cases exceeded 11 million on Friday, according to a Reuters tally, marking another milestone in the spread of the disease that has killed

Ripretinib extends survival when all else fails in advanced GIST

By Reuters Staff NEW YORK (Reuters Health) - Treatment with oral ripretinib significantly prolonged survival in patients with advanced gastrointestinal stromal tumors (GIST) who did not respond or

Flualprazolam: new psychoactive substance of abuse in adolescents

By Will Boggs MD NEW YORK (Reuters Health) - Flualprazolam is a newly identified psychoactive substance of abuse in adolescents, researchers report. "Doctors should be suspicious for flualprazolam

Enzalutamide improves survival in men with metastatic prostate cancer

By Will Boggs MD NEW YORK (Reuters Health) - Enzalutamide improves five-year survival in men with chemotherapy-naive metastatic castration-resistant prostate cancer (mCRPC), but increases the risk of

Ultrasound-mediated transdermal medication may relieve zoster-associated allodynia

By Reuters Staff NEW YORK (Reuters Health) - Ultrasound-mediated transdermal lidocaine and capsaicin appears to relieve pain and emotional distress related to allodynia caused by herpes zoster,

E-cigarettes tied to lower sperm counts in young men

By Marilynn Larkin NEW YORK (Reuters Health) - Use of e-cigarettes, like regular cigarette smoking, was associated with lower sperm counts among young men in an observational study. Drs. Laerke

Health experts cast doubt on India's timeline for COVID vaccine

By Devjyot Ghoshal and Sachin Ravikumar NEW DELHI/BENGALURU (Reuters) - The chief of India's top clinical research agency said in a leaked letter circulated on Friday it envisaged launching a novel

German scientists start nationwide antibody study

By Reuters Staff REUTLINGEN, Germany (Reuters) - German scientists began a nationwide study on Friday to gain a better overview of the actual prevalence of the new coronavirus in the country's

Gilead's COVID-19 antiviral remdesivir gets conditional EU clearance

By Philip Blenkinsop BRUSSELS (Reuters) - The European Commission said on Friday it had given conditional approval for the use of antiviral remdesivir in severe COVID-19 patients following an

Pre-pandemic survey data reveal healthcare workers' opinions of respirators

By Carolyn Crist NEW YORK (Reuters Health) - Personal protective equipment (PPE) such as respirators often interfere with patient care, according to survey results collected before the COVID-19

WHO sees first results from COVID drug trials within two weeks

By Reuters Staff GENEVA (Reuters) - The World Health Organization expects initial results within two weeks from clinical trials it is conducting of drugs that might be effective in treating COVID-19

Britain mulls joining EU's coronavirus vaccine scheme

By Reuters Staff LONDON/BRUSSELS (Reuters) - Britain is discussing with the European Union whether it will join a plan by the bloc to secure supplies of potential vaccines against COVID-19, officials

Pitavastatin potently reduces cholesterol levels

By Will Boggs MD NEW YORK (Reuters Health) - Pitavastatin potently reduces LDL cholesterol levels in patients with and without cardiovascular disease, according to a new Cochrane review. "When the

Five-protein panel promising as biomarker for ureteropelvic junction obstruction

By Anne Harding NEW YORK (Reuters Health) - A panel of five proteins offers promise as a biomarker for kidney damage in ureteropelvic junction obstruction (UPJO), new research shows. "We're starting

Thyroid function tied to mortality in NAFLD

By Reuters Staff NEW YORK (Reuters Health) - Nonalcoholic fatty liver disease (NAFLD) in combination with low thyroid function is associated with an increased risk of all-cause and cardiovascular

Critically ill children more likely to die when underweight, but not when obese

By Linda Carroll (Reuters Health) - Being underweight may raise mortality risk among children who are critically ill, but being overweight appears to have no impact, a new study suggests. In an

Regeneron, Sanofi arthritis drug fails late-stage study in COVID-19 patients

By Reuters Staff (Reuters) - Regeneron Pharmaceuticals Inc and Sanofi said on Thursday their rheumatoid arthritis drug Kevzara failed to meet the main goals of a late-stage study testing it in COVID-

COVID-19 associated loss of smell, taste mostly resolves within weeks

By Linda Carroll (Reuters Health) - Most adults with a mild form of COVID-19 who have lost their ability to taste or smell as an early disease symptom will get those senses back, at least in part, a

Pharmacists expanded their antimicrobial stewardship role during pandemic

By Marilynn Larkin NEW YORK (Reuters Health) - To help limit hospital staff contact with SARS-CoV-2 patients, pharmacists at a university hospital consolidated the number of times medications needed

Aimmune says patients begin treatment with peanut allergy drug as COVID-19 lockdowns ease

By Carl O'Donnell and Manas Mishra (Reuters) - Aimmune Therapuetics Inc said its peanut allergy drug, whose launch had been paused because of coronavirus lockdowns, is again being administered to

Health workers with appropriate PPE don't get COVID-19

By Lisa Rappaport (Reuters Health) - Health workers who have appropriate personal protective equipment (PPE) including protective suits, masks, gloves, goggles, face shields, and gowns don't develop

Sierra Leone doctors' strike leaves COVID-19 patients stranded

By Cooper Inveen Freetown (Reuters) - Doctors treating COVID-19 patients in Sierra Leone went on strike on Thursday over unpaid bonuses, leaving patients in some of the main treatment centres without

Moderna's COVID-19 vaccine trial delayed - STAT

By Reuters Staff (Reuters) - Shares of Moderna Inc fell 7% on Thursday after medical news site STAT reported a delay in a large trial testing the biotech's potential coronavirus vaccine as the company

NIH Director Collins optimistic on COVID-19 vaccine by year end

By Reuters Staff NEW YORK (Reuters) - The U.S. National Institutes of Health's director said on Thursday that he was optimistic that the Trump administration's vaccine-acceleration program, Operation

COVID-19 lockdowns pose weight-related health risks for obese people

By Lisa Rappaport (Reuters Health) - Many people with obesity who don't test positive for SARS-CoV-2 still face health risks from weight-related behaviors like less frequent or intense exercise, and

OCT angiography demonstrates retinal involvement in amblyopia

By Will Boggs MD NEW YORK (Reuters Health) - Optical coherence tomography angiography (OCT-A) could play a role in diagnosing and understanding the pathogenesis of amblyopia, researchers in Hong Kong

U.S. Supreme Court rebuffs abortion clinic protest zone challenges

By Lawrence Hurley WASHINGTON (Reuters) - The U.S. Supreme Court on Thursday left in place policies in Chicago and Pennsylvania's capital Harrisburg that place limits on anti-abortion activists

Hospitals face visitor-restriction dilemmas for children during COVID-19

By Carolyn Crist NEW YORK (Reuters Health) - Hospitals that have imposed strict visitor restriction policies to stop the spread of COVID-19 may need to weigh the benefits and risks of allowing family

Liver fibrosis tied to ventilator need in COVID-19

By David Douglas NEW YORK (Reuters Health) - Middle-aged COVID-19 patients showing signs of advanced liver fibrosis, as estimated by the Fibrosis Index Based on 4 Factors (FIB-4), are at greater

Telephone interventions might relieve some symptoms in adults with cancer

By Will Boggs MD NEW YORK (Reuters Health) - Telephone interventions offer some relief of depression and other symptoms in adults with cancer, but the certainty of evidence is generally low, according

Florida shatters records with over 10,000 new COVID-19 cases in single day

By Lisa Shumaker (Reuters) - Florida shattered records on Thursday when it reported over 10,000 new coronavirus cases, the biggest one-day increase in the state since the pandemic started, according

ART regimen linked to lower COVID-19 risk in people with HIV

By Anne Harding NEW YORK (Reuters Health) - COVID-19 incidence and severity are lower in people with HIV who are taking tenofovir disoproxil fumarate (TDF)/emtricitabine (FTC) compared to those on

U.S. Supreme Court sends Indiana abortion cases back to lower courts

By Lawrence Hurley WASHINGTON (Reuters) - The U.S. Supreme Court on Thursday sent two Indiana abortion disputes back to lower courts including a fight over a restriction that would require women to

European agency backs synthetic crab blood for medical safety tests

By Reuters Staff ZURICH (Reuters) - Companies can use a synthetic alternative to the blood of horseshoe crabs in safety tests for medical products, a European agency has ruled, in a boost for wildlife

REFILE-COVID-19 related MIS-C in kids can spark a treatable type of heart failure

(Refiling 5/21 story to address formatting issues experienced by some clients.) By Linda Carroll (Reuters Health) - Researchers have described the diagnoses and treatment as well as initial warning

Tesla to make molecule printers for German COVID-19 vaccine developer CureVac

By Reuters Staff (Reuters) - Tesla Inc is building mobile molecule printers to help make the potential COVID-19 vaccine being developed by CureVac in Germany, the electric-car maker's Chief Executive

EXPLAINER-How U.S. airlines are trying to stop COVID-19 on flights

By Tracy Rucinski CHICAGO (Reuters) - As some Americans prepare to travel for the July 4 holiday weekend, and airlines slowly ramp up service, the U.S. government has not changed rules for air travel

COVID-19 strain in recent Beijing outbreak may have come from SE Asia

By Reuters Staff SHANGHAI (Reuters) - A strain of COVID-19 that has infected more than 300 people in Beijing since early June could have originated in South or Southeast Asia, according to a study by

As cases in Tokyo surge, Japan gives expert advisory panel a makeover

By Rocky Swift and Linda Sieg TOKYO (Reuters) - With new coronavirus cases in Tokyo surging to a two-month high, Japan faces the prospect of a second wave without the experts who tackled the first

Proportion of COVID-19 contacts reached by English test and trace scheme falls

By Reuters Staff LONDON (Reuters) - Less than three-quarters of close contacts of positive COVID-19 cases identified by England's test and trace system were reached in the latest weekly figures,

Popular fireworks release toxic metals into the air

By Linda Carroll (Reuters Health) - Commonly used fireworks release metals such as lead and titanium into the air as they explode, with potentially adverse effects on human lungs, a new study suggests

Mild liver enzyme increases seen in COVID-19 patients in China

By Marilynn Larkin NEW YORK (Reuters Health) - Close to 30% of COVID-19 patients presented with mildly elevated liver enzymes in a retrospective study in China. Enzyme levels did not rise

U.S. primary care shutdown losses projected at $15 billion

By Lisa Rappaport (Reuters Health) - Primary care practices are projected to have combined revenue losses of $15.1 billion due to dramatic declines in office visits from March to May 2020 during COVID

Left atrial appendage closure noninferior to DOACs for afib when bleeding risk is high

By Marilynn Larkin NEW YORK (Reuters Health) - In patients with atrial fibrillation at high risk for stroke and bleeding, percutaneous left atrial appendage closure (LAAC) was noninferior to direct

Brazil to test Sinovac's potential vaccine against COVID-19 in six states

By Reuters Staff SAO PAULO (Reuters) - A potential coronavirus vaccine developed by China's Sinovac will be tested in Brazil by 12 research centers in 6 Brazilian states, the governor of Sao Paulo

'We are not guinea pigs,' say South African anti-vaccine protesters

By Reuters Staff JOHANNESBURG (Reuters) - Anti-vaccine protesters took to the streets in Johannesburg on Wednesday to voice their concern over Africa's first human trials for a potential coronavirus

World takes stock of COVID-19 drug remdesivir after U.S. snaps up supplies

By Sangmi Cha, Andreas Rinke and Alistair Smout SEOUL/BERLIN/LONDON (Reuters) - Some governments in Europe and Asia said on Wednesday they have enough of Gilead's COVID-19 anti-viral remdesivir for

COVID SCIENCE-Blood cell damage may explain low oxygen levels; two vaccines show promise in early testing

By Nancy Lapid The following is a brief roundup of some of the latest scientific studies on the novel coronavirus and efforts to find treatments and vaccines for COVID-19, the illness caused by the

WHO warns some nations still face 'long, hard' battle with COVID-19

By Emma Farge and John Revill GENEVA (Reuters) - Nations who fail to use every mechanism available to combat the still-raging novel coronavirus will struggle to beat it, the World Health Organization

As Japan re-opens, a hospital grapples with coronavirus aftermath

By Mari Saito and Ami Miyazaki YOKOHAMA (Reuters) - Doctors in white coats and blue scrubs sat around a conference room table in June, looking up at a colourful slide projected on the wall. "How is

Oxford COVID-19 vaccine developers encouraged by immune response but cautious on timeframe

By Reuters Staff LONDON (Reuters) - A leading scientist behind the University of Oxford's potential COVID-19 vaccine said on Wednesday the team has seen the right sort of immune response in trials but

Liquid biopsy promising in spotting kidney cancer

By David Douglas NEW YORK (Reuters Health) - An assay employing plasma and urine cell-free (cf) DNA methylomes is capable of classifying patients across all stages of renal-cell carcinoma (RCC),

Replacing N95 masks with P100 elastomeric masks could save money during pandemic

By Scott Baltic NEW YORK (Reuters Health) - Replacing disposable N95 masks with industrial-style elastomeric masks that use disposable P100 filters is practical and cost-saving, a trial program at a

Liver complications common with COVID-19

By Will Boggs MD NEW YORK (Reuters Health) - Liver complications are common and are associated with more severe disease in patients with COVID-19, according to a new review. "The data confirms that

Statin therapy tied to lower risk of dying from ovarian cancer

By Megan Brooks NEW YORK (Reuters Health) - In a large observational study of women with epithelial ovarian cancer, use of a cholesterol-lowering statin was associated with a significant reduction in

Brains of older adults often harbor four common proteinopathies

By Reuters Staff NEW YORK (Reuters Health) - The presence of four misfolded proteins linked to neurodegeneration is common in the brains of older adults and is associated with dementia and impaired

COVID-19 stress could increase mental-health risks for kids, teens

By Carolyn Crist NEW YORK (Reuters Health) - The COVID-19 pandemic will continue to affect vulnerable groups of children, especially those who are homeless, in foster care, struggle with substance-use

Digital health aids electrophysiology practice during COVID-19 pandemic and beyond

By Will Boggs MD NEW YORK (Reuters Health) - Digital health can facilitate electrophysiology practice for patients with arrhythmia during and after the COVID-19 pandemic, according to an international

U.S. COVID-19 deaths likely higher than reported -U.S. study

By Deena Beasley (Reuters) - The number of Americans who died from COVID-19 in March through May was likely significantly higher than the official U.S. count due in part to state-level reporting

FACTBOX-New drug launches stalled by COVID-19 pandemic

By Carl O'Donnell and Manas Mishra (Reuters) - The U.S. Food and Drug Administration has approved more than 30 new drugs since January. So far, five medicines have seen their commercial launches

FOCUS-From Parkinson's to peanut allergy, pandemic puts brakes on new drugs

By Carl O'Donnell and Manas Mishra (Reuters) - Treatments for peanut allergy and Parkinson's disease are among U.S. drug launches that have been postponed by the COVID-19 pandemic as drugmakers

U.S. FDA issues guidance for COVID-19 vaccine approval

By Manojna Maddipatla and Dania Nadeem (Reuters) - The U.S. Food and Drug Administration on Tuesday released guidance for approving a coronavirus vaccine, saying the vaccine has to prevent or decrease

BioNTech and Pfizer's COVID-19 vaccine shows potential in human trial

By Ludwig Burger and Patricia Weiss FRANKFURT (Reuters) - A COVID-19 vaccine developed by German biotech firm BioNTech and U.S. pharmaceutical giant Pfizer has shown potential and was found to be well

Patients misconstrue terms clinicians use to discuss kidney health

By Lisa Rappaport (Reuters Health) - Many patients may not understand terms like "end-stage kidney disease," which adds to their distress and even trauma when discussing renal health with clinicians,

Neonatal SARS-CoV-2 may present with hypoxemia without respiratory distress

By Lisa Rappaport (Reuters Health) - Neonatal SARS-CoV-2 infection may present in the first days of life with clinically significant hypoxemia in a newborn that doesn't have overt signs of respiratory

Combined oral contraceptives tied to increased bone mass in premature ovarian insufficiency

By Marilynn Larkin NEW YORK (Reuters Health) - In women with premature ovarian insufficiency (POI), combined oral contraceptives (COCs) use was associated with increased bone mineral density (BMD)

Scottish firm to trial T cells as possible COVID-19 treatment

By Reuters Staff LONDON (Reuters) - A Scottish biotechnology firm said on Tuesday it would start clinical trials on a possible T cell treatment for COVID-19, aimed at reducing the need for intensive

Bavaria's free COVID-19 test for all splits Germany

By Joseph Nasr BERLIN (Reuters) - The state of Bavaria approved plans on Tuesday for universal testing for COVID-19, prompting debate elsewhere in Germany about whether to follow suit or stick with

Drugs, doctors and donors: Pakistanis turn to 'Corona Warriors' Facebook group

By Umar Farooq ISTANBUL (Reuters) - When musician Zoraiz Riaz set up a Facebook group to help coordinate convalescent plasma donations for people fighting COVID-19 in Pakistan, he expected perhaps a

Inovio's COVID-19 vaccine candidate shows promise in small early-stage trial

By Trisha Roy and Manas Mishra (Reuters) - An experimental coronavirus vaccine developed by Inovio Pharmaceuticals Inc showed promise and was found to be safe in an early-stage human trial, the

U.S. top medical experts rebuke American Airlines for filling planes

By David Shepardson and Tracy Rucinski WASHINGTON/CHICAGO (Reuters) - Top U.S. health experts on Tuesday criticized American Airlines and other carriers for filling planes to capacity, saying it sends

Fauci says no guarantee U.S. will have effective COVID-19 vaccine, warns spread 'could get very bad'

By Paul Simao and Carl O'Donnell WASHINGTON (Reuters) - The United States cannot count on the availability of a safe and effective COVID-19 vaccine, the government's top infectious diseases expert

Sweden starts critical look at its pandemic response

By Reuters Staff STOCKHOLM (Reuters) - Sweden on Tuesday announced a commission to evaluate its response to the novel coronavirus, reacting to criticism over a death toll that has far exceeded that of

Young adults with early-onset cancer may benefit from genetic testing

By Megan Brooks NEW YORK (Reuters Health) - Young adults with early-onset cancers often harbor germline mutations and would benefit from germline genetic testing, according to a new study. "Although

Tanezumab has small effect on difficult-to-treat chronic low-back pain, may cause joint problems in some

By Will Boggs MD NEW YORK (Reuters Health) - Tanezumab produces a small reduction in pain and improves function in patients with chronic low-back pain not adequately controlled by standard-of-care

Glucose-lowering drugs equally effective as initial treatment for type 2 diabetes

By Will Boggs MD NEW YORK (Reuters Health) - Metformin and other monotherapies for type 2 diabetes have similar effectiveness as initial treatment for patients at low cardiovascular risk, according to

Researchers find no sign of link between chilblains, SARS-CoV-2 infection

By Will Boggs MD NEW YORK (Reuters Health) - Although several adults and children have developed chilblains during the COVID-19 pandemic, two new European case series find no evidence of a causal link

Better data shed more light on ulcerative colitis surgery

By Reuters Staff NEW YORK (Reuters Health) - An inflammatory bowel disease (IBD) surgery registry that adds IBD-specific variables to general quality measurements for restorative proctocolectomy with

MS patients on disease-modifying therapies have lower risk of severe COVID-19

By Reuters Staff NEW YORK (Reuters Health) - Age, obesity and disease severity are the most important independent risk factors for severe COVID-19 in people with multiple sclerosis (MS), while

Global COVID-19 prevention trial of hydroxychloroquine to resume

By Kate Kelland LONDON (Reuters) - A global trial designed to test whether the anti-malaria drugs hydroxychloroquine and chloroquine can prevent infection with COVID-19 is to restart after being

Six months after 'viral pneumonia', Wuhan returning to normal, with masks

By Xihao Jiang and Martin Quin Pollard WUHAN, China/BEIJING (Reuters) - Six months after the World Health Organization learned of "viral pneumonia" cases that would become the COVID-19 pandemic, life

China study warns of new flu virus in pigs with pandemic potential

By David Stanway SHANGHAI (Reuters) - A new flu virus found in Chinese pigs has features that make it more infectious to humans and needs to be watched closely in case it becomes a potential pandemic

Italian whole-town study finds 40% of coronavirus cases had no symptoms

By Kate Kelland LONDON (Reuters) - A study of coronavirus infections that covered almost everyone in the quarantined north Italian town of Vò found that 40% of cases showed no symptoms - suggesting

EXCLUSIVE-After pandemic, U.S. senators want review of drug supply chain

By Patricia Zengerle WASHINGTON (Reuters) - Republican and Democratic U.S. senators called for a government analysis of foreign influence in the U.S. pharmaceutical supply chain on Tuesday, saying the

Nurse understaffing and increased workload associated with multiple organ failure

By Lisa Rappaport (Reuters Health) - Lower nurse staffing levels and increased nurse workload are associated with a greater proportion of patients with multiple organ failure, a Finnish study suggests

Masked Madrid health workers sing, weep and call for job security

By Reuters Staff MADRID (Reuters) - Health workers in scrubs and face masks gathered in central Madrid's Puerta del Sol Square on Monday, demanding better terms for work in a system that was

Nobel laureates call for coronavirus vaccines to be available for all

By Darnell Christie LONDON (Thomson Reuters Foundation) - Nobel peace laureate Desmond Tutu and actor George Clooney are among more than 100 people who have signed an appeal for COVID-19 vaccines to

COVID SCIENCE-'Tentacles' on cells may help virus spread to other cells; risk not significantly higher in people with HIV

By Nancy Lapid (Reuters) - The following is a brief roundup of some of the latest scientific studies on the novel coronavirus and efforts to find treatments and vaccines for COVID-19, the illness

News

Pubmed articles

Medical Jobs